Clinical trials
Phase 1 Multiple Sclerosis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
| Not yet recruiting | 5 |
| Withdrawn | 3 |
| Completed | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Daishi Tian | 3 |
| Tongji Hospital | 3 |
| Tianjin Huanhu Hospital | 2 |
| Beijing Boren Hospital | 1 |
| Guangzhou Lupeng Pharmaceutical Company LTD. | 1 |
| Huashan Hospital | 1 |
| RenJi Hospital | 1 |
| Sanofi | 1 |
| The Affiliated Hospital of Qingdao University | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 17 |
| Myasthenia Gravis | 9 |
| Neuromyelitis Optica | 8 |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 5 |
| Autoimmune Diseases of the Nervous System | 4 |
| Lupus Erythematosus, Systemic | 3 |
| Myositis | 3 |
| Scleroderma, Systemic | 3 |
| Recurrence | 2 |
| Anemia, Hemolytic, Autoimmune | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.